Delivery Order SPE2DX22D0079-SPE2D825FAES9
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $181,081.98 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract under which AmerisourceBergen will supply pharmaceutical products and medical supplies to support federal military and healthcare operations. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $91,278.31 firm fixed price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The contract will be performed at the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,413.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with ultimate completion by August 5, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger indefinite delivery vehicle, this award reflects AmerisourceBergen's role...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,034.30 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,483.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order was placed with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $141,525.64 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical and medical supply products. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $12,476.60 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is an unclassified, competitively awarded contract utilizing firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under a larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,967.30 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,532.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,413.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation and will be performed at the vendor's...
- SPE2DX22D0079Indefinite Delivery Contract
- SPE2DX22D0079-SPE2D825FAES9Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $296,361.86 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor supplying comprehensive medical commodities including brand-name and generic medications, vaccines, medical devices, and specialized healthcare products to support military and veteran healthcare systems. This delivery order is a child contract under the company's $999,999,999.00 Pharmaceutical Prime Vendor Global Program (SPE2DX) agreement running through December 2026, which enables AmerisourceBergen to supply pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $296.4k | 8/4/25 |